chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Medication error, No adverse event, Poor quality product administered
Clinical narrative: inadvertently administered a dose of Pentacel that had been exposed for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees F with no adverse event; Initial information received on 15-Feb-2023 regarding an unsolicited valid  non-serious case received via other health professional.  This case involves a 1 years old female patient who was diagnosed with inadvertently administered a dose of pentacel that had been exposed for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees f with no adverse event after receiving vaccine diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine [Pentacel].  The patient's past medical history, medical treatment(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE for Prophylactic vaccination.  On 08-Feb-2023, the patient received suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine at dose of 0.5 ml at dose series 4 (strength, frequency, formulation, route, expiry date: unknown) (lot UJ682AAA) via intramuscular route in unknown administration site for prophylactic vaccination (immunization).  On 08-Feb-2023 the patient diagnosed with a non-serious inadvertently administered a dose of pentacel that had been exposed for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees f with no adverse event (poor quality product administered) following the administration of diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine.  Action taken was not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.67
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Medication error, No adverse event, Poor quality product administered, Product storage error
Clinical narrative: patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event; patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event; Initial information received on 15-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 8 months old female patient who was inadvertently administered a dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE (PNEUMOCOCCAL VACCINE) for Prophylactic vaccination.  On 10-Feb-2023, the patient received a 0.5 ml dose 1 of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (strength, expiry date, formulation: unknown, lot UJ682AAA) via intramuscular route in the left thigh as immunization.  On 10-Feb-2023 the patient was inadvertently administered a dose of pentacel that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event (poor quality product administered) (product storage error).  No lab data was reported.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event, patient was inadvertently administered a dose of Pentacel that had been exposed to minimum temperature of 30 degrees F for 3 hours and 15 minutes with no reported adverse event).  At time of reporting, the outcome was Unknown for the event patient was inadvertently administered a dose of pentacel that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event and was Unknown for the event patient was inadvertently administered a dose of pentacel that had been exposed to minimum temperature of 30 degrees f for 3 hours and 15 minutes with no reported adverse event.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.17
Sex: M
Vaccine: UNK
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: inadvertently administered a dose of pentacel that had been exposed to temperatures lower than recommended for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees with no adverse event reported; inadvertently administered a dose of pentacel that had been exposed to temperatures lower than recommended for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees with no adverse event reported; Initial information received on 15-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 2 months old male patient who inadvertently received a dose of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine [Pentacel (Vero)] that had been exposed to temperatures lower than recommended for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees with no adverse event reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Pneumococcal vaccine and Rotavirus vaccine for Prophylactic vaccination.  On 09-Feb-2023, the patient who received a dose 1 of 0.5 ml with frequency 1X (once) of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine [Pentacel (Vero)] that had been exposed to temperatures lower than recommended for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees with no adverse event reported (poor quality product administered) (latency: same day) (lot: UJ682AAA, expiry date: unknown) of form: Suspension for injection, via intramuscular route in left leg with unknown strength for Immunization.  On an unknown date the patient received a dose of pentacel that had been exposed to temperatures lower than recommended for 3 hours and 15 minutes, reaching a minimum temperature of 30 degrees with no adverse event reported (product storage error) (unknown latency).  Action taken: not applicable.  Outcome: Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: patient was administered expired MENACTRA that expired 8 days ago with no reported adverse event; Initial information received on 16-Feb-2023 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves a 12-year-old female patient who was administered expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] that expired 8 days ago with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL) for Immunisation; and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for Immunisation.  On 16-Feb-2023, the patient received dose 1 at 0.5ml total of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (Strength: standard; formulation: unknown) (lot number: U7207AA, expiry date: 08-Feb-2023) via intramuscular route in left deltoid for Immunization and on the same day patient was administered expired menactra that expired 8 days ago with no reported adverse event (expired product administered).  It was reported, caller requesting information on MENACTRA. Wanting to know next steps to take. This situation is reported as a medication error due to expired MENACTRA being administered to a patient   Action taken with MENINGOCOCCAL VACCINE (MENACTRA) was not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Extra dose administered
Clinical narrative: Patient received doses of  MMRV and Kinrix on 1/7/2022. Received another dose of MMRV and Kinrix on 2/7/2023.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Angiogram cerebral, Angiogram pulmonary, Antibody test, Audiogram, Blood immunoglobulin G
Clinical narrative: Shot felt like it was given high in my left arm.  To this day my left arm is not working properly and hurts still in injection site. Goes to my shoulder and all the way to my middle of my crease in my elbow and my grip in my left hand is diminished day by day and now really bad.Immediately after I did not feel well. I sat in the wait room for about 20-30 minutes after. Then I went home and got on the couch and was down about 4 days not feeling well. My body felt like a truck ran over me.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Cardiac monitoring, Differential white blood cell count, Echocardiogram, Electrocardiogram, Feeling abnormal
Clinical narrative: Shot felt like it was given high in my left arm.  To this day my left arm is not working properly and hurts still in injection site. Goes to my shoulder and all the way to my middle of my crease in my elbow and my grip in my left hand is diminished day by day and now really bad.Immediately after I did not feel well. I sat in the wait room for about 20-30 minutes after. Then I went home and got on the couch and was down about 4 days not feeling well. My body felt like a truck ran over me.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Full blood count, Grip strength decreased, Impaired work ability, Injection site pain, Laboratory test
Clinical narrative: Shot felt like it was given high in my left arm.  To this day my left arm is not working properly and hurts still in injection site. Goes to my shoulder and all the way to my middle of my crease in my elbow and my grip in my left hand is diminished day by day and now really bad.Immediately after I did not feel well. I sat in the wait room for about 20-30 minutes after. Then I went home and got on the couch and was down about 4 days not feeling well. My body felt like a truck ran over me.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Magnetic resonance imaging head, Malaise, Pain in extremity, Product administered at inappropriate site, Scan with contrast
Clinical narrative: Shot felt like it was given high in my left arm.  To this day my left arm is not working properly and hurts still in injection site. Goes to my shoulder and all the way to my middle of my crease in my elbow and my grip in my left hand is diminished day by day and now really bad.Immediately after I did not feel well. I sat in the wait room for about 20-30 minutes after. Then I went home and got on the couch and was down about 4 days not feeling well. My body felt like a truck ran over me.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Shot felt like it was given high in my left arm.  To this day my left arm is not working properly and hurts still in injection site. Goes to my shoulder and all the way to my middle of my crease in my elbow and my grip in my left hand is diminished day by day and now really bad.Immediately after I did not feel well. I sat in the wait room for about 20-30 minutes after. Then I went home and got on the couch and was down about 4 days not feeling well. My body felt like a truck ran over me.
Age: 10.0
Sex: M
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: No adverse reactions noted. Vaccine was given today, 02/20/2023 but the product expired on 02/16/2023.
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event, Product preparation error, Underdose
Clinical narrative: There were 4-5 individuals at the local clinic on 1/19/23 that received the 6 months to 5 years monovalent formulation due to a preparation error. Clinic is unable determine which 4-5 individuals out of 14 actually received the monovalent formulation instead of the intended bivalent product.  Moderna monovalent Lot number was AS1414B with manufacturer expiration date of 2/13/23.  No symptoms of adverse reaction
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event, Product preparation error, Underdose
Clinical narrative: There were 4-5 individuals at the clinic on 1/19/23 that received the 6 months to 5 years monovalent formulation due to a preparation error. Clinic is unable determine which 4-5 individuals out of 14 actually received the monovalent formulation instead of the intended bivalent product.  Moderna monovalent Lot number was AS1414B with manufacturer expiration date of 2/13/23.  No adverse reaction symptoms
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT MADE AN APPOINTMENT FOR A SECOND DOSE MONOVALENT VACCINE. PATIENT WAS ELIGIBLE FOR A BIVALENT BOOSTER ONLY.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event, Product preparation error, Underdose
Clinical narrative: There were 4-5 individuals at the local clinic on 1/19/23 that received the 6 months to 5 years monovalent formulation due to a preparation error. Clinic is unable determine which 4-5 individuals out of 14 actually received the monovalent formulation instead of the intended bivalent product.  Moderna monovalent Lot number was AS1414B with manufacturer expiration date of 2/13/23.  No adverse reactions
Age: 52.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Incorrect product formulation administered, No adverse event, Product preparation error, Underdose
Clinical narrative: There were 4-5 individuals at the local clinic on 1/19/23 that received the 6 months to 5 years monovalent formulation due to a preparation error. Clinic is unable determine which 4-5 individuals out of 14 actually received the monovalent formulation instead of the intended bivalent product.  Moderna monovalent Lot number was AS1414B with manufacturer expiration date of 2/13/23.  No adverse reaction symptoms
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event, Product preparation error, Underdose
Clinical narrative: There were 4-5 individuals at the local clinic on 1/19/23 that received the 6 months to 5 years monovalent formulation due to a preparation error. Clinic is unable to determine which 4-5 individuals out of 14 actually received the monovalent formulation instead of the intended bivalent product.  Moderna monovalent Lot number was AS1414B with manufacturer expiration date of 2/13/23.  No adverse reaction symptoms
Age: 30.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Back pain, Immunisation reaction, Injection site nodule, Lymphadenopathy
Clinical narrative: Patient called this morning to report an adverse reaction to her vaccine she received  Thursday evening. She said her throat felt constricted and she took a Benadryl and that resolved that issue but she also has lymph node swelling under her armpit, shoulder and back pain, and a knot at the injection site. She followed up with her doctor who stated she might be allergic and that happens from time to time with the lymph node swelling. Patient has shoulder and back pain still and lymph node swelling .
Age: 30.0
Sex: F
Vaccine: TDAP
Symptoms: Throat tightness
Clinical narrative: Patient called this morning to report an adverse reaction to her vaccine she received  Thursday evening. She said her throat felt constricted and she took a Benadryl and that resolved that issue but she also has lymph node swelling under her armpit, shoulder and back pain, and a knot at the injection site. She followed up with her doctor who stated she might be allergic and that happens from time to time with the lymph node swelling. Patient has shoulder and back pain still and lymph node swelling .
Age: 57.0
Sex: F
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: Expired vaccine was administered.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Impaired work ability, Influenza virus test negative, Nasal congestion, Oropharyngeal pain
Clinical narrative: I started to have aches, fever, sore throat, and nasal congestion. I went to my PCP, who tested me for various flu strains, RSV, and COVID-19, I tested positive for COVID-19 and negative for everything else. My PCP prescribed me Paxlovid. I took the medicine and had to wait for about five days before I could return to work. It was about day seven or day eight that I finally got a negative result on a home antigen test.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: I started to have aches, fever, sore throat, and nasal congestion. I went to my PCP, who tested me for various flu strains, RSV, and COVID-19, I tested positive for COVID-19 and negative for everything else. My PCP prescribed me Paxlovid. I took the medicine and had to wait for about five days before I could return to work. It was about day seven or day eight that I finally got a negative result on a home antigen test.
Age: 51.0
Sex: F
Vaccine: PNC20
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Patient stated that when she woke up this morning she had a red, raised bump that was 2 inches below the vaccination site. The bump became flatter through the day, but the redness spread below the initial site. Patient also stated it was warm to the touch.
Age: 49.0
Sex: M
Vaccine: UNK
Symptoms: Balance disorder, Blood test, Coordination abnormal, Electrocardiogram, Guillain-Barre syndrome
Clinical narrative: It began with feet and toes going numb / painful / stiff/pins and needles / paralysis / neuropathy; these same symptoms also spread to the hands and was rapidly followed by severe balance and coordination issues. I was admitted to Hospital and eventually diagnosed with Guillain-Barre syndrome. Hospital course was IVIG, lumbar puncture, MRIs, respiratory tests, urological tests, many neurological test, EKGs, nerve induction test, urinalysis, many blood draws, physical therapy, occupational therapy, speech services and other tests and treatments I don't recall. I was eventually discharged to hospitalized rehabilitation, followed by physical therapy occupational therapy and speech therapy at home and then eventually outpatient physical therapy occupational therapy and speech services which I am still attending. Multiple issues have manifested/not resolved.
Age: 49.0
Sex: M
Vaccine: UNK
Symptoms: Hypoaesthesia, Immunoglobulin therapy, Laboratory test, Lumbar puncture, Magnetic resonance imaging
Clinical narrative: It began with feet and toes going numb / painful / stiff/pins and needles / paralysis / neuropathy; these same symptoms also spread to the hands and was rapidly followed by severe balance and coordination issues. I was admitted to Hospital and eventually diagnosed with Guillain-Barre syndrome. Hospital course was IVIG, lumbar puncture, MRIs, respiratory tests, urological tests, many neurological test, EKGs, nerve induction test, urinalysis, many blood draws, physical therapy, occupational therapy, speech services and other tests and treatments I don't recall. I was eventually discharged to hospitalized rehabilitation, followed by physical therapy occupational therapy and speech therapy at home and then eventually outpatient physical therapy occupational therapy and speech services which I am still attending. Multiple issues have manifested/not resolved.
Age: 49.0
Sex: M
Vaccine: UNK
Symptoms: Musculoskeletal stiffness, Nerve conduction studies, Neuropathy peripheral, Pain in extremity, Paraesthesia
Clinical narrative: It began with feet and toes going numb / painful / stiff/pins and needles / paralysis / neuropathy; these same symptoms also spread to the hands and was rapidly followed by severe balance and coordination issues. I was admitted to Hospital and eventually diagnosed with Guillain-Barre syndrome. Hospital course was IVIG, lumbar puncture, MRIs, respiratory tests, urological tests, many neurological test, EKGs, nerve induction test, urinalysis, many blood draws, physical therapy, occupational therapy, speech services and other tests and treatments I don't recall. I was eventually discharged to hospitalized rehabilitation, followed by physical therapy occupational therapy and speech therapy at home and then eventually outpatient physical therapy occupational therapy and speech services which I am still attending. Multiple issues have manifested/not resolved.
Age: 49.0
Sex: M
Vaccine: UNK
Symptoms: Paralysis, Urine analysis
Clinical narrative: It began with feet and toes going numb / painful / stiff/pins and needles / paralysis / neuropathy; these same symptoms also spread to the hands and was rapidly followed by severe balance and coordination issues. I was admitted to Hospital and eventually diagnosed with Guillain-Barre syndrome. Hospital course was IVIG, lumbar puncture, MRIs, respiratory tests, urological tests, many neurological test, EKGs, nerve induction test, urinalysis, many blood draws, physical therapy, occupational therapy, speech services and other tests and treatments I don't recall. I was eventually discharged to hospitalized rehabilitation, followed by physical therapy occupational therapy and speech therapy at home and then eventually outpatient physical therapy occupational therapy and speech services which I am still attending. Multiple issues have manifested/not resolved.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Headache, Injection site pain, Injection site swelling, Lymph node pain
Clinical narrative: Pain at the site, extreme swelling at site, headache, nausea, diarrhea, pain under right arm in armpit lymph nodes with swelling on the 11th day.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Lymphadenopathy, Nausea
Clinical narrative: Pain at the site, extreme swelling at site, headache, nausea, diarrhea, pain under right arm in armpit lymph nodes with swelling on the 11th day.
Age: 54.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site pain, Pain, Pain in extremity
Clinical narrative: pt reports pain in left arm at and below the injection site.  It is a shooting pain down arm to below elbow.  Deltoid to mid lower arm.  When rotating arm it hurts.  Still having symptoms now 2/20/23 after injection given 10/28/22.  RPh advised pt share this info with primary care physician.  Pt plans to meet with PCP soon- in the next week or so.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse event noted patient received a dose that had been out of the freezer for >30 days
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Genital herpes, Herpes simplex, Herpes simplex reactivation
Clinical narrative: recurrence of long dormant HSV2 (genital herpes)
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Activated partial thromboplastin time, Angiogram cerebral normal, Anticoagulant therapy, Arteriogram carotid normal, Balance disorder
Clinical narrative: Twenty-four days after receiving the Covid Bilavent Booster, I had an Ischemic Stroke.  Upon waking up at approx. 9:00 am on November 28, 2022, I noticed some brain fogginess and occaisional bluriness. I proceeded with my day noticing little things along the way but attributed all of it to a lack of sleep. I spilled my coffee trying to sip it, I was off slightly balance when I turned a corner in my hallway causing my shoulder to brush the wall, I would occaisionly not lift my foot high enough on the stairs and would trip slightly. My daughters were noticing I slurred my words a little but I joke around all the time and we just laughed at it, again thinking it was because I was tired. I was on vacation ContinuedBelow
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test, Cerebrovascular accident, Cognitive disorder, Computerised tomogram head abnormal, Dysarthria
Clinical narrative: Twenty-four days after receiving the Covid Bilavent Booster, I had an Ischemic Stroke.  Upon waking up at approx. 9:00 am on November 28, 2022, I noticed some brain fogginess and occaisional bluriness. I proceeded with my day noticing little things along the way but attributed all of it to a lack of sleep. I spilled my coffee trying to sip it, I was off slightly balance when I turned a corner in my hallway causing my shoulder to brush the wall, I would occaisionly not lift my foot high enough on the stairs and would trip slightly. My daughters were noticing I slurred my words a little but I joke around all the time and we just laughed at it, again thinking it was because I was tired. I was on vacation ContinuedBelow
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Electrocardiogram abnormal, Facial paralysis, Fatigue, Feeling abnormal, Full blood count abnormal
Clinical narrative: Twenty-four days after receiving the Covid Bilavent Booster, I had an Ischemic Stroke.  Upon waking up at approx. 9:00 am on November 28, 2022, I noticed some brain fogginess and occaisional bluriness. I proceeded with my day noticing little things along the way but attributed all of it to a lack of sleep. I spilled my coffee trying to sip it, I was off slightly balance when I turned a corner in my hallway causing my shoulder to brush the wall, I would occaisionly not lift my foot high enough on the stairs and would trip slightly. My daughters were noticing I slurred my words a little but I joke around all the time and we just laughed at it, again thinking it was because I was tired. I was on vacation ContinuedBelow
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Gait disturbance, Haemoglobin, Haemorrhagic stroke, Impaired driving ability, International normalised ratio
Clinical narrative: Twenty-four days after receiving the Covid Bilavent Booster, I had an Ischemic Stroke.  Upon waking up at approx. 9:00 am on November 28, 2022, I noticed some brain fogginess and occaisional bluriness. I proceeded with my day noticing little things along the way but attributed all of it to a lack of sleep. I spilled my coffee trying to sip it, I was off slightly balance when I turned a corner in my hallway causing my shoulder to brush the wall, I would occaisionly not lift my foot high enough on the stairs and would trip slightly. My daughters were noticing I slurred my words a little but I joke around all the time and we just laughed at it, again thinking it was because I was tired. I was on vacation ContinuedBelow
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ischaemic stroke, Lipids, Magnetic resonance imaging head abnormal, Magnetic resonance imaging neck, Metabolic function test abnormal
Clinical narrative: Twenty-four days after receiving the Covid Bilavent Booster, I had an Ischemic Stroke.  Upon waking up at approx. 9:00 am on November 28, 2022, I noticed some brain fogginess and occaisional bluriness. I proceeded with my day noticing little things along the way but attributed all of it to a lack of sleep. I spilled my coffee trying to sip it, I was off slightly balance when I turned a corner in my hallway causing my shoulder to brush the wall, I would occaisionly not lift my foot high enough on the stairs and would trip slightly. My daughters were noticing I slurred my words a little but I joke around all the time and we just laughed at it, again thinking it was because I was tired. I was on vacation ContinuedBelow
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Prothrombin time, Thalamic stroke, Vision blurred
Clinical narrative: Twenty-four days after receiving the Covid Bilavent Booster, I had an Ischemic Stroke.  Upon waking up at approx. 9:00 am on November 28, 2022, I noticed some brain fogginess and occaisional bluriness. I proceeded with my day noticing little things along the way but attributed all of it to a lack of sleep. I spilled my coffee trying to sip it, I was off slightly balance when I turned a corner in my hallway causing my shoulder to brush the wall, I would occaisionly not lift my foot high enough on the stairs and would trip slightly. My daughters were noticing I slurred my words a little but I joke around all the time and we just laughed at it, again thinking it was because I was tired. I was on vacation ContinuedBelow
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Inflammatory marker increased, Mobility decreased
Clinical narrative: 2 Days after injection, developed extreme inflammation in all joints. Could barely get out of bed. By the 3rd day I was almost crippled.  Had to find an endocrine doctor and was placed on prednisone for 10 months till the markers came down. Since tapering off the prednisone, I have been much better, and markers have been down consistently. I am a perfectly healthy 65 year old man who is extremely active, and still works.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was supposed to receive a first dose of the Pfizer COVID-19 vaccine primary series (monovalent), however, pharmacy staff inadvertently gave a dose of Pfizer Bivalent Booster vaccine.
Age: 65.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Malaise, Rash
Clinical narrative: patient didn't feel well for 2 days after vaccines but on 4th day started developing a rash on the arms and by 6th day rash was spreading to her back and lower body . told patient contact primary care doctor to see if he felt treatment was necessary
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute kidney injury, COVID-19, Condition aggravated, Cough
Clinical narrative: ADMITTED TO HOSPITAL ON 5/20/22 WITH ABDOMINAL PAIN, NAUSEA, AND VOMITING; ALSO HAS COUGH AND MILD DYSPNEA. HYPOXIC AFTER ADMISSION.  UNKNOWN WHEN PATIENT WAS DISCHARGED FROM HOSPITAL PRIOR TO DEATH.  CAUSE OF DEATH ON DEATH CERTIFICATE LISTED AS - SMALL BOWEL OBSTRUCTION, ACUTE KIDNEY FAILURE, COVID-19, HYPERTENSIVE CARDIOVASCULAR DISEASE, AND DIABETES.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Diabetes mellitus, Dyspnoea, Hypertensive heart disease, Hypoxia
Clinical narrative: ADMITTED TO HOSPITAL ON 5/20/22 WITH ABDOMINAL PAIN, NAUSEA, AND VOMITING; ALSO HAS COUGH AND MILD DYSPNEA. HYPOXIC AFTER ADMISSION.  UNKNOWN WHEN PATIENT WAS DISCHARGED FROM HOSPITAL PRIOR TO DEATH.  CAUSE OF DEATH ON DEATH CERTIFICATE LISTED AS - SMALL BOWEL OBSTRUCTION, ACUTE KIDNEY FAILURE, COVID-19, HYPERTENSIVE CARDIOVASCULAR DISEASE, AND DIABETES.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test positive, Small intestinal obstruction, Vomiting
Clinical narrative: ADMITTED TO HOSPITAL ON 5/20/22 WITH ABDOMINAL PAIN, NAUSEA, AND VOMITING; ALSO HAS COUGH AND MILD DYSPNEA. HYPOXIC AFTER ADMISSION.  UNKNOWN WHEN PATIENT WAS DISCHARGED FROM HOSPITAL PRIOR TO DEATH.  CAUSE OF DEATH ON DEATH CERTIFICATE LISTED AS - SMALL BOWEL OBSTRUCTION, ACUTE KIDNEY FAILURE, COVID-19, HYPERTENSIVE CARDIOVASCULAR DISEASE, AND DIABETES.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: UNKNOWN
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Brain natriuretic peptide increased, COVID-19, Chest X-ray, Dehydration
Clinical narrative: 1. COVID-19 Infection 1. Date of onset of symptoms: 1/10/23 2. Symptoms present on admission: Hypoxemia 3. Date of covid positive test: 1/12/23 4. Vaccination status:  Pfizer x2, No boosters 5. Imaging:  CXR reviewed 6. Oxygen requirements on admission:   4L 7. Current oxygen requirements: room air 8. Medical therapy: Adding Decadron 9. Consultants following:  E-consult placed for ID (Spoke with staff in person). 10. Anticipated special isolation end date: 1/22/23 2. Elevated BNP 1. Appears chronically elevated.  2. Patient appears euvolemic.  3. Acute on Chronic CKD - ACUTE RESOLVED 1. Cr 1.77 on admission 2. 1/13/22 is now 1.37 with IVF 3. Baseline is 1.3-1.4 4. Will stop IVF 4. Diabetes Type II 1. SSI 2. Monitor BG 3. Diabetic Diet as tolerated 5. Elevated Delta Difference Troponin 1 1. Level 18 on 1/12. Will re-check now.  2. Highly likely this is related to deconditioned, dehydrated state s/t COVID-19. 3. Home Eliquis dosing continued. 4. Denies CP 6. Other Chronic Conditions include: Dementia, Stroke, HTN, HLF, CAD, Systolic Heart Failure, OA
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Physical deconditioning, SARS-CoV-2 test positive, Troponin I increased
Clinical narrative: 1. COVID-19 Infection 1. Date of onset of symptoms: 1/10/23 2. Symptoms present on admission: Hypoxemia 3. Date of covid positive test: 1/12/23 4. Vaccination status:  Pfizer x2, No boosters 5. Imaging:  CXR reviewed 6. Oxygen requirements on admission:   4L 7. Current oxygen requirements: room air 8. Medical therapy: Adding Decadron 9. Consultants following:  E-consult placed for ID (Spoke with staff in person). 10. Anticipated special isolation end date: 1/22/23 2. Elevated BNP 1. Appears chronically elevated.  2. Patient appears euvolemic.  3. Acute on Chronic CKD - ACUTE RESOLVED 1. Cr 1.77 on admission 2. 1/13/22 is now 1.37 with IVF 3. Baseline is 1.3-1.4 4. Will stop IVF 4. Diabetes Type II 1. SSI 2. Monitor BG 3. Diabetic Diet as tolerated 5. Elevated Delta Difference Troponin 1 1. Level 18 on 1/12. Will re-check now.  2. Highly likely this is related to deconditioned, dehydrated state s/t COVID-19. 3. Home Eliquis dosing continued. 4. Denies CP 6. Other Chronic Conditions include: Dementia, Stroke, HTN, HLF, CAD, Systolic Heart Failure, OA
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Blood creatinine increased, COVID-19, Cellulitis
Clinical narrative: Patient is a 56 y.o. male patient of DO with history of alcoholic liver cirrhosis, alcohol withdrawal, gastric varices status post banding, iron deficiency anemia, presented on 1/15/2023 with weakness, lightheadedness, fever/chills was admitted to the ICU for septic shock on 1/16/2023 initially requiring pressors. HMS consulted by MD  for transfer of care from ICU to intermediate unit. IR re-consulted for paracentesis today; had 8750 cc of fluid drained. 75g of albumin infusion given   Discharge Diagnoses: Sepsis due to R LE cellulitis Unclear etiology, likely septic shock from RLE cellulitis Or suspected hepatorenal syndrome/COVID infection VSS, BP improved, AF, on 2L NC. AAOX3 Required levophed on adm 1/16, quickly taken off On Midodrine 15 mg TID and octreotide 100 mcg TID VIR c/s for paracentesis 1/17 and removal of 9 liters, no SBP. 100g of albumin given Had repeat paracentesis today with removal of 8750L; 75g of albumin infusion given ID on board; received IV Ancef and completed 7 days of therapy  AKI-improved Adm Cr: 1.4>1.2.GFR:58>70.(Baseline Cr: 0.7-0.9, GFR: >90) Probable cause(s): suspected hepatorenal syndrome/sepsis Avoid nephrotoxic agents including NSAIDs Lasix and aldactone restarted 01/20 Nephrology on board; recommendation appreciated   Covid-19 Virus Infection Date of onset of symptoms: on adm (1/16) Symptoms present on admission:  cough and generalized fatigue on adm (1/16) Date of covid positive test: 1/15/23 Vaccination status: vaccinated Imaging: CXR (1/15/23) Moderate-sized right-sided pleural effusion appears increased.  Oxygen requirements on admission: RA Current oxygen requirements: RA Medical therapy: Dexamethasone and remdesivir started due to hypoxia, which has resolved Consultants following: N/A Anticipated special isolation end date: 1/25/23 ID on board, complete 10 days of Dexa. Remdesivir completed   Alcoholic Liver cirrhosis w/ ascites  Alcohol abuse MELD NA 21 on 1/17/23 Seen by Hepatology 10/14/22 --rec torsemide 20 mg TID.  Noncompliant, patient continues to use alcohol on a weekly basis Overdue for Surveillance EGD (last EGD: 5/2021 S/P banding) Diagnostic paracentesis 1/15/23 (-) SBP or culture growth Therapeutic paracentesis 1/17/23 S/P 9L and 1/23/23 8750L removed.  Albumin given after each session as described above Counseled to quit ETOH use; Lim it acetaminophen < 2 g daily F/u RUQ US w/ dopplers-Cirrhotic liver morphology no masses, Splenomegaly. AFP at 1.3 GI consulted, cont midodrine, 2gm diet Follow up GI as OP
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chills, Cough, Dizziness, Fatigue
Clinical narrative: Patient is a 56 y.o. male patient of DO with history of alcoholic liver cirrhosis, alcohol withdrawal, gastric varices status post banding, iron deficiency anemia, presented on 1/15/2023 with weakness, lightheadedness, fever/chills was admitted to the ICU for septic shock on 1/16/2023 initially requiring pressors. HMS consulted by MD  for transfer of care from ICU to intermediate unit. IR re-consulted for paracentesis today; had 8750 cc of fluid drained. 75g of albumin infusion given   Discharge Diagnoses: Sepsis due to R LE cellulitis Unclear etiology, likely septic shock from RLE cellulitis Or suspected hepatorenal syndrome/COVID infection VSS, BP improved, AF, on 2L NC. AAOX3 Required levophed on adm 1/16, quickly taken off On Midodrine 15 mg TID and octreotide 100 mcg TID VIR c/s for paracentesis 1/17 and removal of 9 liters, no SBP. 100g of albumin given Had repeat paracentesis today with removal of 8750L; 75g of albumin infusion given ID on board; received IV Ancef and completed 7 days of therapy  AKI-improved Adm Cr: 1.4>1.2.GFR:58>70.(Baseline Cr: 0.7-0.9, GFR: >90) Probable cause(s): suspected hepatorenal syndrome/sepsis Avoid nephrotoxic agents including NSAIDs Lasix and aldactone restarted 01/20 Nephrology on board; recommendation appreciated   Covid-19 Virus Infection Date of onset of symptoms: on adm (1/16) Symptoms present on admission:  cough and generalized fatigue on adm (1/16) Date of covid positive test: 1/15/23 Vaccination status: vaccinated Imaging: CXR (1/15/23) Moderate-sized right-sided pleural effusion appears increased.  Oxygen requirements on admission: RA Current oxygen requirements: RA Medical therapy: Dexamethasone and remdesivir started due to hypoxia, which has resolved Consultants following: N/A Anticipated special isolation end date: 1/25/23 ID on board, complete 10 days of Dexa. Remdesivir completed   Alcoholic Liver cirrhosis w/ ascites  Alcohol abuse MELD NA 21 on 1/17/23 Seen by Hepatology 10/14/22 --rec torsemide 20 mg TID.  Noncompliant, patient continues to use alcohol on a weekly basis Overdue for Surveillance EGD (last EGD: 5/2021 S/P banding) Diagnostic paracentesis 1/15/23 (-) SBP or culture growth Therapeutic paracentesis 1/17/23 S/P 9L and 1/23/23 8750L removed.  Albumin given after each session as described above Counseled to quit ETOH use; Lim it acetaminophen < 2 g daily F/u RUQ US w/ dopplers-Cirrhotic liver morphology no masses, Splenomegaly. AFP at 1.3 GI consulted, cont midodrine, 2gm diet Follow up GI as OP
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate decreased, Hepatorenal syndrome, Hypoxia, Infusion, Intensive care
Clinical narrative: Patient is a 56 y.o. male patient of DO with history of alcoholic liver cirrhosis, alcohol withdrawal, gastric varices status post banding, iron deficiency anemia, presented on 1/15/2023 with weakness, lightheadedness, fever/chills was admitted to the ICU for septic shock on 1/16/2023 initially requiring pressors. HMS consulted by MD  for transfer of care from ICU to intermediate unit. IR re-consulted for paracentesis today; had 8750 cc of fluid drained. 75g of albumin infusion given   Discharge Diagnoses: Sepsis due to R LE cellulitis Unclear etiology, likely septic shock from RLE cellulitis Or suspected hepatorenal syndrome/COVID infection VSS, BP improved, AF, on 2L NC. AAOX3 Required levophed on adm 1/16, quickly taken off On Midodrine 15 mg TID and octreotide 100 mcg TID VIR c/s for paracentesis 1/17 and removal of 9 liters, no SBP. 100g of albumin given Had repeat paracentesis today with removal of 8750L; 75g of albumin infusion given ID on board; received IV Ancef and completed 7 days of therapy  AKI-improved Adm Cr: 1.4>1.2.GFR:58>70.(Baseline Cr: 0.7-0.9, GFR: >90) Probable cause(s): suspected hepatorenal syndrome/sepsis Avoid nephrotoxic agents including NSAIDs Lasix and aldactone restarted 01/20 Nephrology on board; recommendation appreciated   Covid-19 Virus Infection Date of onset of symptoms: on adm (1/16) Symptoms present on admission:  cough and generalized fatigue on adm (1/16) Date of covid positive test: 1/15/23 Vaccination status: vaccinated Imaging: CXR (1/15/23) Moderate-sized right-sided pleural effusion appears increased.  Oxygen requirements on admission: RA Current oxygen requirements: RA Medical therapy: Dexamethasone and remdesivir started due to hypoxia, which has resolved Consultants following: N/A Anticipated special isolation end date: 1/25/23 ID on board, complete 10 days of Dexa. Remdesivir completed   Alcoholic Liver cirrhosis w/ ascites  Alcohol abuse MELD NA 21 on 1/17/23 Seen by Hepatology 10/14/22 --rec torsemide 20 mg TID.  Noncompliant, patient continues to use alcohol on a weekly basis Overdue for Surveillance EGD (last EGD: 5/2021 S/P banding) Diagnostic paracentesis 1/15/23 (-) SBP or culture growth Therapeutic paracentesis 1/17/23 S/P 9L and 1/23/23 8750L removed.  Albumin given after each session as described above Counseled to quit ETOH use; Lim it acetaminophen < 2 g daily F/u RUQ US w/ dopplers-Cirrhotic liver morphology no masses, Splenomegaly. AFP at 1.3 GI consulted, cont midodrine, 2gm diet Follow up GI as OP
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Paracentesis, Pleural effusion, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 56 y.o. male patient of DO with history of alcoholic liver cirrhosis, alcohol withdrawal, gastric varices status post banding, iron deficiency anemia, presented on 1/15/2023 with weakness, lightheadedness, fever/chills was admitted to the ICU for septic shock on 1/16/2023 initially requiring pressors. HMS consulted by MD  for transfer of care from ICU to intermediate unit. IR re-consulted for paracentesis today; had 8750 cc of fluid drained. 75g of albumin infusion given   Discharge Diagnoses: Sepsis due to R LE cellulitis Unclear etiology, likely septic shock from RLE cellulitis Or suspected hepatorenal syndrome/COVID infection VSS, BP improved, AF, on 2L NC. AAOX3 Required levophed on adm 1/16, quickly taken off On Midodrine 15 mg TID and octreotide 100 mcg TID VIR c/s for paracentesis 1/17 and removal of 9 liters, no SBP. 100g of albumin given Had repeat paracentesis today with removal of 8750L; 75g of albumin infusion given ID on board; received IV Ancef and completed 7 days of therapy  AKI-improved Adm Cr: 1.4>1.2.GFR:58>70.(Baseline Cr: 0.7-0.9, GFR: >90) Probable cause(s): suspected hepatorenal syndrome/sepsis Avoid nephrotoxic agents including NSAIDs Lasix and aldactone restarted 01/20 Nephrology on board; recommendation appreciated   Covid-19 Virus Infection Date of onset of symptoms: on adm (1/16) Symptoms present on admission:  cough and generalized fatigue on adm (1/16) Date of covid positive test: 1/15/23 Vaccination status: vaccinated Imaging: CXR (1/15/23) Moderate-sized right-sided pleural effusion appears increased.  Oxygen requirements on admission: RA Current oxygen requirements: RA Medical therapy: Dexamethasone and remdesivir started due to hypoxia, which has resolved Consultants following: N/A Anticipated special isolation end date: 1/25/23 ID on board, complete 10 days of Dexa. Remdesivir completed   Alcoholic Liver cirrhosis w/ ascites  Alcohol abuse MELD NA 21 on 1/17/23 Seen by Hepatology 10/14/22 --rec torsemide 20 mg TID.  Noncompliant, patient continues to use alcohol on a weekly basis Overdue for Surveillance EGD (last EGD: 5/2021 S/P banding) Diagnostic paracentesis 1/15/23 (-) SBP or culture growth Therapeutic paracentesis 1/17/23 S/P 9L and 1/23/23 8750L removed.  Albumin given after each session as described above Counseled to quit ETOH use; Lim it acetaminophen < 2 g daily F/u RUQ US w/ dopplers-Cirrhotic liver morphology no masses, Splenomegaly. AFP at 1.3 GI consulted, cont midodrine, 2gm diet Follow up GI as OP